Clinical Trial Update: PrEPared and Strong: Clinic-Based PrEP for Black MSM [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating clinic-based pre-exposure prophylaxis (PrEP) for Black men who have sex with men to prevent HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• Pre-exposure prophylaxis (PrEP)

Snippet

Sponsor: Columbia University | Conditions: HIV/AIDS | Phase 4 | Status: COMPLETED